- ￥3290
- Abbiotec
- 美国
- 600310
- 2025年12月25日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
保存于-229℃
- 保质期：
一年
- 英文名：
Human VEGF-165
- 库存：
一定量库存
- 供应商：
美国ABBIOTEC公司
- 规格：
0.01 mg
Vascular Endothelial Growth Factor (VEGF) is a heparin-binding glycoprotein which can exist in a number of different isoforms. The protein has been found to be a potent inducer of angiogeneis and endothelial cell proliferation, and plays an important role in regulating vasculogenesis. VEGF can be detected in both the plasma and serum and has been implicated in several disease states associated with augmented angiogenesis. Recombinant VEGF-165 comprises a 165 amino acid fragment (5-169) corresponding to the VEGF 165 isoform and is expressed in E. coli with an amino-terminal hexahistidine tag.
形 态 ：
Each vial contains 0.01 mg protein (liquid) in PBS pH7.4, 50% glycerol. Final concentration 0.1-1 mg/ml.
来 源 ：
E. coli
别 名 ：
VEGF-A; Vascular endothelial growth factor; VEGFA; VEGF-A; Glioma-derived growth endothelial growth factor (GD-VEGF); Vasculotrophin (VAS); Vascular endothelial cell proliferation factor; Vascular permeability factor (VPF)
纯 度 ：
Purity > 95% as determined by reducing and non-reducing SDS-PAGE, Bradford assay, Western blot and ELISA.
分子量 ：
23.63 kDa
应 用 ：E, WB
保存条件 ：
Store at -20°C. Product is guaranteed one year from the date of shipment.
产品链接 ：http://www.abbiotec.com/proteins/human-vegf-165-0
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification of Human Complement Protein C5
Complement C5 is cleaved by proteolysis in the terminal phase of complement activation generating the pro-inflammatory C5a and membrane attack complex nucleator C5b. Whereas purification of its paralogues C3 and C4 from plasma is relatively
Analysis of Protein Phosphorylation in Human Neutrophils
, serines and threonines. Upon covalent binding of phosphates to these amino acids, the charge and conformation of the corresponding proteins are modified, generally leading to changes in protein functions such as protein-protein interactions and enzymatic
Protein Components of the microRNA Pathway and Human Diseases
or dysfunction of specific miRNAs. It has been appreciated only recently that diseases may also develop when the protein components of the miRNA machinery itself are affected. The core enzymes of the major protein complexes involved in miRNA biogenesis
技术资料暂无技术资料 索取技术资料
